Pfizer Inc. (BMV:PFE)

Market Cap	2.58T
Revenue (ttm)	1.28T
Net Income (ttm)	161.05B
Shares Out	n/a
EPS (ttm)	28.26
PE Ratio	16.01
Forward PE	8.05
Dividend	33.26 (7.65%)
Ex-Dividend Date	May 9, 2025

Volume	128,468
Average Volume	15,323
Open	432.12
Previous Close	435.03
Day's Range	432.12 - 453.00
52-Week Range	431.86 - 597.50
Beta	0.50
RSI	43.79
Earnings Date	Apr 29, 2025

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1849
• Employees: 81,000
• Stock Exchange: Mexican Stock Exchange
• Ticker Symbol: PFE

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD